Markers for Characterization of Bone Marrow Multipotential Stromal Cells

Given the observed efficacy of culture-expanded multipotential stromal cells, also termed mesenchymal stem cells (MSCs), in the treatment of graft-versus host and cardiac disease, it remains surprising that purity and potency characterization of manufactured cell batches remains rather basic. In thi...

Full description

Bibliographic Details
Main Authors: Boxall, Sally A., Jones, Elena
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361338/
id pubmed-3361338
recordtype oai_dc
spelling pubmed-33613382012-06-04 Markers for Characterization of Bone Marrow Multipotential Stromal Cells Boxall, Sally A. Jones, Elena Review Article Given the observed efficacy of culture-expanded multipotential stromal cells, also termed mesenchymal stem cells (MSCs), in the treatment of graft-versus host and cardiac disease, it remains surprising that purity and potency characterization of manufactured cell batches remains rather basic. In this paper, we will initially discuss surface and molecular markers that were proposed to serve as the indicators of the MSC potency, in terms of their proliferative potential or the ability to differentiate into desired lineages. The second part of this paper will be dedicated to a critical discussion of surface markers of uncultured (i.e., native) bone marrow (BM) MSCs. Although no formal consensus has yet been reached on which markers may be best suited for prospective BM MSC isolation, markers that cross-react with MSCs of animal models (such as CD271 and W8-B2/MSCA-1) may have the strongest translational value. Whereas small animal models are needed to discover the in vivo function on these markers, large animal models are required for safety and efficacy testing of isolated MSCs, particularly in the field of bone and cartilage tissue engineering. Hindawi Publishing Corporation 2012 2012-05-14 /pmc/articles/PMC3361338/ /pubmed/22666272 http://dx.doi.org/10.1155/2012/975871 Text en Copyright © 2012 S. A. Boxall and E. Jones. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Boxall, Sally A.
Jones, Elena
spellingShingle Boxall, Sally A.
Jones, Elena
Markers for Characterization of Bone Marrow Multipotential Stromal Cells
author_facet Boxall, Sally A.
Jones, Elena
author_sort Boxall, Sally A.
title Markers for Characterization of Bone Marrow Multipotential Stromal Cells
title_short Markers for Characterization of Bone Marrow Multipotential Stromal Cells
title_full Markers for Characterization of Bone Marrow Multipotential Stromal Cells
title_fullStr Markers for Characterization of Bone Marrow Multipotential Stromal Cells
title_full_unstemmed Markers for Characterization of Bone Marrow Multipotential Stromal Cells
title_sort markers for characterization of bone marrow multipotential stromal cells
description Given the observed efficacy of culture-expanded multipotential stromal cells, also termed mesenchymal stem cells (MSCs), in the treatment of graft-versus host and cardiac disease, it remains surprising that purity and potency characterization of manufactured cell batches remains rather basic. In this paper, we will initially discuss surface and molecular markers that were proposed to serve as the indicators of the MSC potency, in terms of their proliferative potential or the ability to differentiate into desired lineages. The second part of this paper will be dedicated to a critical discussion of surface markers of uncultured (i.e., native) bone marrow (BM) MSCs. Although no formal consensus has yet been reached on which markers may be best suited for prospective BM MSC isolation, markers that cross-react with MSCs of animal models (such as CD271 and W8-B2/MSCA-1) may have the strongest translational value. Whereas small animal models are needed to discover the in vivo function on these markers, large animal models are required for safety and efficacy testing of isolated MSCs, particularly in the field of bone and cartilage tissue engineering.
publisher Hindawi Publishing Corporation
publishDate 2012
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361338/
_version_ 1611532811486887936